Lisa Gill
Stock Analyst at JP Morgan
(3.47)
# 860
Out of 4,778 analysts
136
Total ratings
51.69%
Success rate
2.76%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $21.12 | +42.05% | 2 | Mar 19, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $35.19 | +16.51% | 4 | Mar 6, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $17.59 | -3.35% | 4 | Mar 6, 2025 | |
| HUM Humana | Maintains: Neutral | $257 → $256 | $273.99 | -6.57% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $66.51 | +21.80% | 5 | Feb 18, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $173 → $180 | $165.73 | +8.61% | 2 | Feb 4, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $142 → $145 | $132.75 | +9.23% | 6 | Feb 4, 2025 | |
| COR Cencora | Maintains: Overweight | $289 → $301 | $268.47 | +12.12% | 2 | Jan 24, 2025 | |
| PACS PACS Group | Downgrades: Neutral | $18 | $11.34 | +58.73% | 2 | Dec 17, 2024 | |
| INNV InnovAge Holding | Downgrades: Underweight | $5 | $2.99 | +67.22% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $24.21 | +15.65% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $28 | $22.75 | +23.08% | 4 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $15 | $11.13 | +34.83% | 14 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $8.65 | +4.11% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $22 → $18 | $8.81 | +104.31% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $664.00 | -0.45% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $316.54 | +38.37% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $13.11 | +37.30% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $310.53 | +27.20% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $234.45 | +3.65% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $185.92 | +0.04% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $546 → $559 | $513.45 | +8.87% | 5 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $130.82 | +7.02% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $336.38 | -1.30% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $628 → $631 | $423.64 | +48.95% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.56 | +119.30% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $4.48 | +101.12% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $5.51 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $6.75 | +18.52% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $69.37 | +19.65% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $58.94 | +66.27% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $26 → $24 | $31.24 | -23.16% | 4 | Jun 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.95 | - | 4 | Dec 19, 2017 |
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $21.12
Upside: +42.05%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $35.19
Upside: +16.51%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $17.59
Upside: -3.35%
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $273.99
Upside: -6.57%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $66.51
Upside: +21.80%
Quest Diagnostics
Feb 4, 2025
Maintains: Neutral
Price Target: $173 → $180
Current: $165.73
Upside: +8.61%
Cardinal Health
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $132.75
Upside: +9.23%
Cencora
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $268.47
Upside: +12.12%
PACS Group
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $11.34
Upside: +58.73%
InnovAge Holding
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $2.99
Upside: +67.22%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $24.21
Upside: +15.65%
Nov 29, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $22.75
Upside: +23.08%
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $11.13
Upside: +34.83%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $8.65
Upside: +4.11%
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $8.81
Upside: +104.31%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $664.00
Upside: -0.45%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $316.54
Upside: +38.37%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $13.11
Upside: +37.30%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $310.53
Upside: +27.20%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $234.45
Upside: +3.65%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $185.92
Upside: +0.04%
May 30, 2024
Maintains: Overweight
Price Target: $546 → $559
Current: $513.45
Upside: +8.87%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $130.82
Upside: +7.02%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $336.38
Upside: -1.30%
May 30, 2024
Maintains: Overweight
Price Target: $628 → $631
Current: $423.64
Upside: +48.95%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.56
Upside: +119.30%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $4.48
Upside: +101.12%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $5.51
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $6.75
Upside: +18.52%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $69.37
Upside: +19.65%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $58.94
Upside: +66.27%
Jun 7, 2018
Maintains: Underweight
Price Target: $26 → $24
Current: $31.24
Upside: -23.16%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $18.95
Upside: -